Family business

Growing up, PSA’s 2023 Intern of the Year Grace Quach had more opportunity than most to see the difference pharmacists make to their patients.

Dapagliflozin for infertility for women with obesity

This glucose-lowering diabetes drug may have therapeutic benefits and clinical utility for people with reproductive dysfunction.

What transpired at the inaugural GP-Pharmacists Symposium?

PSA's inaugural GP Pharmacists Symposium underscored the expanding scope of the profession – and the policy gaps that still need closing.

Medicinal cannabis: Patient access and clinical evidence

In the August 2017 edition of Australian Pharmacist (page 10), I provided background on the regulatory scheme for cultivation and manufacture of medicinal cannabis,...

2022: a year in review

From a difficult start to a triumphant end, here are the most significant events that impacted pharmacy practice in 2022.

NDSS changes to assist in diabetes management

Changes to the Australian Government’s National Diabetes Services Scheme (NDSS) took effect on 1 December, altering the range and price of certain products available...